PortfoliosLab logo
ACHC vs. COST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ACHC and COST is 0.53, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

ACHC vs. COST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Acadia Healthcare Company, Inc. (ACHC) and Costco Wholesale Corporation (COST). The values are adjusted to include any dividend payments, if applicable.

0.00%5,000.00%10,000.00%15,000.00%December2025FebruaryMarchAprilMay
-0.67%
14,229.84%
ACHC
COST

Key characteristics

Sharpe Ratio

ACHC:

-1.22

COST:

1.39

Sortino Ratio

ACHC:

-1.91

COST:

1.96

Omega Ratio

ACHC:

0.72

COST:

1.27

Calmar Ratio

ACHC:

-0.84

COST:

1.81

Martin Ratio

ACHC:

-1.53

COST:

5.32

Ulcer Index

ACHC:

42.35%

COST:

5.89%

Daily Std Dev

ACHC:

54.77%

COST:

21.91%

Max Drawdown

ACHC:

-98.67%

COST:

-53.39%

Current Drawdown

ACHC:

-73.23%

COST:

-6.26%

Fundamentals

Market Cap

ACHC:

$2.20B

COST:

$450.29B

EPS

ACHC:

$2.78

COST:

$17.15

PE Ratio

ACHC:

8.58

COST:

59.18

PEG Ratio

ACHC:

1.32

COST:

5.34

PS Ratio

ACHC:

0.71

COST:

1.71

PB Ratio

ACHC:

0.72

COST:

17.49

Total Revenue (TTM)

ACHC:

$2.39B

COST:

$264.09B

Gross Profit (TTM)

ACHC:

$1.72B

COST:

$35.11B

EBITDA (TTM)

ACHC:

$445.44M

COST:

$11.25B

Returns By Period

In the year-to-date period, ACHC achieves a -39.87% return, which is significantly lower than COST's 10.29% return. Over the past 10 years, ACHC has underperformed COST with an annualized return of -9.89%, while COST has yielded a comparatively higher 23.69% annualized return.


ACHC

YTD

-39.87%

1M

-18.08%

6M

-41.60%

1Y

-66.18%

5Y*

-2.14%

10Y*

-9.89%

COST

YTD

10.29%

1M

4.58%

6M

7.07%

1Y

30.07%

5Y*

29.12%

10Y*

23.69%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ACHC vs. COST — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ACHC
The Risk-Adjusted Performance Rank of ACHC is 33
Overall Rank
The Sharpe Ratio Rank of ACHC is 11
Sharpe Ratio Rank
The Sortino Ratio Rank of ACHC is 33
Sortino Ratio Rank
The Omega Ratio Rank of ACHC is 22
Omega Ratio Rank
The Calmar Ratio Rank of ACHC is 44
Calmar Ratio Rank
The Martin Ratio Rank of ACHC is 66
Martin Ratio Rank

COST
The Risk-Adjusted Performance Rank of COST is 8888
Overall Rank
The Sharpe Ratio Rank of COST is 9090
Sharpe Ratio Rank
The Sortino Ratio Rank of COST is 8585
Sortino Ratio Rank
The Omega Ratio Rank of COST is 8585
Omega Ratio Rank
The Calmar Ratio Rank of COST is 9292
Calmar Ratio Rank
The Martin Ratio Rank of COST is 8787
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ACHC vs. COST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Acadia Healthcare Company, Inc. (ACHC) and Costco Wholesale Corporation (COST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current ACHC Sharpe Ratio is -1.22, which is lower than the COST Sharpe Ratio of 1.39. The chart below compares the historical Sharpe Ratios of ACHC and COST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00December2025FebruaryMarchAprilMay
-1.22
1.39
ACHC
COST

Dividends

ACHC vs. COST - Dividend Comparison

ACHC has not paid dividends to shareholders, while COST's dividend yield for the trailing twelve months is around 0.47%.


TTM20242023202220212020201920182017201620152014
ACHC
Acadia Healthcare Company, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
COST
Costco Wholesale Corporation
0.47%0.49%2.87%0.76%0.54%3.38%0.86%1.08%4.81%1.09%4.06%0.97%

Drawdowns

ACHC vs. COST - Drawdown Comparison

The maximum ACHC drawdown since its inception was -98.67%, which is greater than COST's maximum drawdown of -53.39%. Use the drawdown chart below to compare losses from any high point for ACHC and COST. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-73.23%
-6.26%
ACHC
COST

Volatility

ACHC vs. COST - Volatility Comparison

Acadia Healthcare Company, Inc. (ACHC) has a higher volatility of 18.44% compared to Costco Wholesale Corporation (COST) at 5.91%. This indicates that ACHC's price experiences larger fluctuations and is considered to be riskier than COST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%December2025FebruaryMarchAprilMay
18.44%
5.91%
ACHC
COST

Financials

ACHC vs. COST - Financials Comparison

This section allows you to compare key financial metrics between Acadia Healthcare Company, Inc. and Costco Wholesale Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00BAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025
774.24M
63.72B
(ACHC) Total Revenue
(COST) Total Revenue
Values in USD except per share items

ACHC vs. COST - Profitability Comparison

The chart below illustrates the profitability comparison between Acadia Healthcare Company, Inc. and Costco Wholesale Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025
96.3%
15.1%
(ACHC) Gross Margin
(COST) Gross Margin
ACHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Acadia Healthcare Company, Inc. reported a gross profit of 745.68M and revenue of 774.24M. Therefore, the gross margin over that period was 96.3%.

COST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Costco Wholesale Corporation reported a gross profit of 9.61B and revenue of 63.72B. Therefore, the gross margin over that period was 15.1%.

ACHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Acadia Healthcare Company, Inc. reported an operating income of 103.46M and revenue of 774.24M, resulting in an operating margin of 13.4%.

COST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Costco Wholesale Corporation reported an operating income of 2.32B and revenue of 63.72B, resulting in an operating margin of 3.6%.

ACHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Acadia Healthcare Company, Inc. reported a net income of 32.62M and revenue of 774.24M, resulting in a net margin of 4.2%.

COST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Costco Wholesale Corporation reported a net income of 1.79B and revenue of 63.72B, resulting in a net margin of 2.8%.